MarketCap
Facebook
X
TelegramQuarterly report 2024-Q4
added 01-10-2025
Accolade Total Assets 2011-2026 | ACCD
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Accolade
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 476 M | 124 M | 65.8 M | 47.1 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 476 M | 47.1 M | 178 M |
Quarterly Total Assets Accolade
| 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 647 M | 756 M | 767 M | 788 M | 785 M | 854 M | 876 M | 903 M | 914 M | 932 M | 944 M | 1.29 B | 1.26 B | 1.27 B | 891 M | 476 M | 467 M | 267 M | 120 M | 73.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.29 B | 73.2 M | 764 M |
Total Assets of other stocks in the Health information services industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
American Well Corporation
AMWL
|
324 M | $ 5.46 | - | $ 87.6 M |  USA |
 |
Cerner Corporation
CERN
|
7.43 B | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
434 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
3.41 B | - | - | $ 2.94 B | USA |
 |
Castlight Health, Inc.
CSLT
|
167 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
1.33 B | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
1.97 B | - | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
37.5 M | - | - | $ 102 M | USA |
 |
1Life Healthcare
ONEM
|
2.63 B | - | - | $ 3.37 B | USA |
 |
Akerna Corp.
KERN
|
7.63 M | - | - | $ 161 M | USA |
 |
HealthStream
HSTM
|
511 M | $ 22.05 | 1.61 % | $ 670 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
2.43 B | - | -10.39 % | $ 886 M | USA |
 |
Evolent Health
EVH
|
1.82 B | $ 3.55 | - | $ 333 M | USA |
 |
HealthEquity
HQY
|
3.16 B | $ 81.15 | - | $ 6.94 B | USA |
 |
MTBC
MTBC
|
71.6 M | - | -0.58 % | $ 51.7 M | USA |
 |
Change Healthcare
CHNG
|
9.93 B | - | - | $ 9.03 B | USA |
 |
Omnicell
OMCL
|
2.12 B | $ 41.53 | 1.79 % | $ 1.91 B | USA |
 |
GoodRx Holdings
GDRX
|
1.39 B | $ 2.18 | 5.31 % | $ 841 M | USA |
 |
Health Catalyst
HCAT
|
859 M | $ 1.95 | 13.37 % | $ 117 M | USA |
 |
Progyny
PGNY
|
607 M | $ 17.79 | 1.54 % | $ 1.53 B | USA |
 |
Premier
PINC
|
3.1 B | - | - | $ 2.33 B | USA |
 |
So-Young International
SY
|
2.74 B | $ 2.88 | - | $ 229 M |  China |
 |
Teladoc Health
TDOC
|
2.86 B | $ 5.13 | - | $ 904 M | USA |
 |
10x Genomics
TXG
|
965 M | $ 22.37 | -1.11 % | $ 2.62 B | USA |
 |
R1 RCM
RCM
|
1.45 B | - | - | $ 3.81 B | USA |
 |
Veeva Systems
VEEV
|
5.91 B | $ 188.48 | 0.13 % | $ 30.3 B | USA |
 |
NantHealth
NH
|
160 M | - | -46.64 % | $ 10.4 M | USA |
 |
OptimizeRx Corporation
OPRX
|
183 M | $ 7.87 | 7.51 % | $ 135 M | USA |
 |
NextGen Healthcare
NXGN
|
644 M | - | - | $ 1.6 B | USA |
 |
SCWorx Corp.
WORX
|
6.35 M | $ 0.13 | - | $ 190 K | USA |
 |
Phreesia
PHR
|
370 M | $ 12.63 | - | $ 689 M | USA |
 |
Schrödinger
SDGR
|
726 M | $ 13.12 | 4.96 % | $ 964 M | USA |
 |
Zhongchao
ZCMD
|
25.9 M | $ 1.67 | -3.14 % | $ 8.69 M | China |
 |
Signify Health
SGFY
|
1.74 B | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
35.6 M | - | - | $ 21.4 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
384 M | - | - | $ 255 M | USA |